Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Primo N Lara

Showing results (151-160 of 274) with videos related to

Pageof 28
Sort By:
Urologic Oncology|October 5, 2010
Identification of a bladder cancer-specific ligand using a combinatorial chemistry approachHongyong Zhang, Olulanu H Aina, Kit S Lam, et al.
Clinical Lung Cancer|December 31, 2005
Therapeutic strategies for combined-modality therapy of locally advanced non-small-cell lung cancer: rationale for consolidation docetaxel therapyDavid R Gandara, Eric Vallières, Laurie E Gaspar, et al.
Cancer|August 14, 2002
HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening TrialPrimo N Lara, Frederick J Meyers, Carl R Gray, et al.
Cancer|March 29, 2016
A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancerHelen Chow, Paramita M Ghosh, Ralph deVere White, et al.
Cancer|March 18, 2011
Secondary malignancies among nonseminomatous germ cell tumor cancer survivorsKarim Chamie, Eric A Kurzrock, Christopher P Evans, et al.
Clinical Lung Cancer|August 6, 2013
Chemotherapy outcomes by histologic subtypes of non-small-cell lung cancer: analysis of the southwest oncology group database for antimicrotubule-platinum therapyKaren Kelly, Kari Chansky, Philip C Mack, et al.
Cancer Research Communications|April 20, 2026
Capturing Latino Health Disparities: Lessons from Mail- and Community-Based Population Health Surveys in CaliforniaApril P Vang, Juanita Elizabeth Quino, Angelica M Rolon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2009
EGFR mutations detected in plasma are associated with patient outcomes in erlotinib plus docetaxel-treated non-small cell lung cancerPhilip C Mack, William S Holland, Rebekah A Burich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222Quynh-Thu X Le, James Moon, Mary Redman, et al.
Clinical Lung Cancer|October 8, 2009
Cooperative group research endeavors in small-cell lung cancer: current and future directionsRandeep Sangha, Primo N Lara, Alex A Adjei, et al.
Pageof 28

Showing results (151-160 of 274) with videos related to

Sort By:
Pageof 28
Urologic Oncology|October 5, 2010
Identification of a bladder cancer-specific ligand using a combinatorial chemistry approachHongyong Zhang, Olulanu H Aina, Kit S Lam, et al.
Clinical Lung Cancer|December 31, 2005
Therapeutic strategies for combined-modality therapy of locally advanced non-small-cell lung cancer: rationale for consolidation docetaxel therapyDavid R Gandara, Eric Vallières, Laurie E Gaspar, et al.
Cancer|August 14, 2002
HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening TrialPrimo N Lara, Frederick J Meyers, Carl R Gray, et al.
Cancer|March 29, 2016
A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancerHelen Chow, Paramita M Ghosh, Ralph deVere White, et al.
Cancer|March 18, 2011
Secondary malignancies among nonseminomatous germ cell tumor cancer survivorsKarim Chamie, Eric A Kurzrock, Christopher P Evans, et al.
Clinical Lung Cancer|August 6, 2013
Chemotherapy outcomes by histologic subtypes of non-small-cell lung cancer: analysis of the southwest oncology group database for antimicrotubule-platinum therapyKaren Kelly, Kari Chansky, Philip C Mack, et al.
Cancer Research Communications|April 20, 2026
Capturing Latino Health Disparities: Lessons from Mail- and Community-Based Population Health Surveys in CaliforniaApril P Vang, Juanita Elizabeth Quino, Angelica M Rolon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2009
EGFR mutations detected in plasma are associated with patient outcomes in erlotinib plus docetaxel-treated non-small cell lung cancerPhilip C Mack, William S Holland, Rebekah A Burich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222Quynh-Thu X Le, James Moon, Mary Redman, et al.
Clinical Lung Cancer|October 8, 2009
Cooperative group research endeavors in small-cell lung cancer: current and future directionsRandeep Sangha, Primo N Lara, Alex A Adjei, et al.
Pageof 28